-PTI/ Livemint.com * Being Health Minister of the country, how justified is it to release such falsely fabricated unscientific product, the IMA statement said * The IMA statement further said: Can you clarify the time frame, time line for the so-called clinical trial of this said anti-corona product The Indian Medical Association (IMA) on Monday said that it shocked over Patanjali Ayurveda's "blatant lie of WHO certification" for Coronil tablet, which the company...

-The Hindu India is working on a multi-pronged strategy to reduce this reliance. China still remains the largest source of critical imports for India, from mobile phone components to pharmaceutical ingredients, and India is working on a multi-pronged strategy to reduce this reliance, which is a bigger concern than the imbalance in trade. “The trade deficit is not in dollars, it is in overdependence,” said Sanjay Chadha, Additional Secretary in the Ministry of...

-The Indian Express The current scenario is ideal for policymakers and practitioners to drive home the importance of health spending and institutional development With the first batch of anti-COVID vaccines being rolled out, the mood of the nation seems to be upbeat as it bids farewell to the pain and anguish of last year. The emergency-use approval to the vaccine developed by Oxford University and the Swedish-British pharma major AstraZeneca, manufactured in...

-The Indian Express Simultaneously, it has started a review of all model concession agreements — the legal contract that forms the basis of the public-private partnership — across four key infrastructure sectors: airports, ports, electricity and railways. AMID the unprecedented concentration of power in at least seven core sectors in corporate India, from pharma and telecom to airports and ports, the Competition Commission of India has launched a set of detailed investigations...

-Livemint.com Unprecedented resources have been marshaled across the world in the race for a covid-19 vaccine, with the US and Germany pumping in most funds The Indian government’s recent letter trying to speed up clinical trials for a vaccine candidate, which it is developing in collaboration with a Hyderabad-based pharmaceutical company, betrayed its desperation to develop the world’s first covid-19 vaccine. But in a historically unparalleled global race for a vaccine, India...